Oligometastases: the art of providing metastases-directed therapy in prostate cancer

Prostate-specific membrane antigen-targeted positron emission tomography has revolutionized prostate cancer diagnostics and holds the potential to advance metastases-directed therapy through, among other treatments, ablative radiotherapy.

Automated summary

Prostate-specific membrane antigen-targeted positron emission tomography has revolutionized prostate cancer diagnostics and has the potential to advance metastases-directed therapy, including ablative radiotherapy.